Charming Medical Limited Class A Ordinary Shares (MCTA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Charming Medical Limited Class A Ordinary Shares stock (MCTA) is currently trading at $29.36. Charming Medical Limited Class A Ordinary Shares PE ratio is 419.36. Charming Medical Limited Class A Ordinary Shares PS ratio (Price-to-Sales) is 81.05. WallStSmart rates MCTA as Sell.
- MCTA PE ratio analysis and historical PE chart
- MCTA PS ratio (Price-to-Sales) history and trend
- MCTA intrinsic value — DCF, Graham Number, EPV models
- MCTA stock price prediction 2025 2026 2027 2028 2029 2030
- MCTA fair value vs current price
- MCTA insider transactions and insider buying
- Is MCTA undervalued or overvalued?
- Charming Medical Limited Class A Ordinary Shares financial analysis — revenue, earnings, cash flow
- MCTA Piotroski F-Score and Altman Z-Score
- MCTA analyst price target and Smart Rating
Charming Medical Limited Class A
📊 No data available
Try selecting a different time range
MCTA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Charming Medical Limited Class A Ordinary Shares (MCTA)
MCTA trades 795% above its Graham fair value of $3.28, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Charming Medical Limited Class A Ordinary Shares (MCTA) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, eps growth, profit margin. Concerns around price/sales and price/book. Mixed signals suggest waiting for clearer direction before acting.
Charming Medical Limited Class A Ordinary Shares (MCTA) Key Strengths (3)
Earnings per share surging 81.00% year-over-year
Strong operational efficiency: $29 kept per $100 revenue
Strong profitability: $19 kept per $100 revenue
Charming Medical Limited Class A Ordinary Shares (MCTA) Areas to Watch (5)
Revenue declining -3.30%, a shrinking business
Very expensive at 81.0x annual revenue
Very expensive at 10240.2x book value
Very low institutional interest at 0.30%
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Charming Medical Limited Class A Ordinary Shares (MCTA) Detailed Analysis Report
Overall Assessment
This company scores 36/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 8.7/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Operating Margin, Profit Margin. Profitability is solid with Operating Margin at 28.90%, Profit Margin at 19.30%. Growth metrics are encouraging with EPS Growth at 81.00%.
The Bear Case
The primary concerns are Revenue Growth, Price/Sales, Price/Book. Some valuation metrics including Price/Sales (81.05), Price/Book (10240.24) suggest expensive pricing. Growth concerns include Revenue Growth at -3.30%, which may limit upside.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at 28.90% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -3.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and Price/Sales are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MCTA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MCTA's Price-to-Sales ratio of 81.05x sits near its historical average of 75.46x (45th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 81.05x set in Mar 2026, and 41% above its historical low of 57.33x in Oct 2025. Over the past 12 months, the PS ratio has expanded from ~57.3x, reflecting growing market expectations outpacing revenue growth.
Compare MCTA with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Charming Medical Limited Class A Ordinary Shares (MCTA) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Charming Medical Limited Class A Ordinary Shares faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 6M with 3% decline year-over-year. Profit margins of 19.3% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 138,361 in free cash flow and 425,888 in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Valuation compression risk at a P/E of 419.4x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Charming Medical Limited Class A Ordinary Shares.
Bottom Line
Charming Medical Limited Class A Ordinary Shares faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Charming Medical Limited Class A Ordinary Shares(MCTA)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Charming Medical Limited, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. The company is headquartered in Causeway Bay, Hong Kong.